President Biden will push private employers to mandate vaccinations for employees. The plan includes mandating vaccines among employees at healthcare facilities that receive Medicare or Medicaid funding. (CNBC Weekly)
The Food and Drug Administration has decided that 5 million e-cigarette products should be removed from the market. But it still hasn’t decided on products by category leaders like Juul and NJoy. (Politico)
Apellis’ pegcetacoplan failed to achieve primary endpoints in a “carbon copy” study following two successful Phase III studies. The drug aims to treat geographic atrophy, a form of age-related macular degeneration, which has no approved therapies. (Endpoints News)
The White House plans to tackle prescription drug prices by allowing Medicare to negotiate pricing, according to a plan the administration released Thursday. “The Biden-Harris administration remains committed to making healthcare more affordable for American families, and this plan outlines one key way we will do that,” HHS Secretary Xavier Becerra said. (The Wall Street Journal)
Biogen’s launch of controversial Alzheimer’s drug Aduhelm was “slower than we anticipated,” company CEO Michel Vounatsos said Thursday. Only 50 or so centers around the U.S. have administered one dose of the drug to date. (STAT)
